SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-103957
Filing Date
2024-09-05
Accepted
2024-09-05 16:00:08
Documents
12
Period of Report
2024-08-29
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K glto-20240829.htm   iXBRL 8-K 61270
2 EX-3.1 glto-ex3_1.htm EX-3.1 11214
  Complete submission text file 0000950170-24-103957.txt   224815

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT glto-20240829.xsd EX-101.SCH 49303
14 EXTRACTED XBRL INSTANCE DOCUMENT glto-20240829_htm.xml XML 5056
Mailing Address 75 STATE STREET SUITE 100 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 100 BOSTON MA 02109 45-70-70-52-10
Galecto, Inc. (Filer) CIK: 0001800315 (see all company filings)

IRS No.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39655 | Film No.: 241281319
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)